Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Stop Big Pharma Profiteering

EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies
EU Governments - Protect our Meds not Their Monopolies

Read, watch, share

Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health. Photo credit: MSF/Martim Gray Pereira
Press release
Press release |
19 March 2026
Pandemic preparedness Research and development
European Union

MSF calls on EU to unlock progress in final Pandemic Agreement talks

2 min
Letter
Letter |
16 March 2026
Research and development
European Union

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

A pharmacist unpacks medications at the mobile clinic pharmacy. Through mobile clinics, MSF provides medical services to local populations. Photograph by Tadeu Andre
Press release
Press release |
14 March 2023
Intellectual property and trade
United KingdomIndiaEuropean Union

News Update: EU-India FTA negotiations could have negative impact on access to medicines

4 min
Report cover image
Letter |
30 June 2021
COVID-19
European Union

Letter to European Commission to stop blocking IP waiver of COVID-19 medical tools

MSF teams providing care to COVID patients in Antonio Lorena hospital, Cusco, Peru. Photograph by Clément Locquet
Press release
Press release |
29 June 2021
COVID-19
European Union

Disingenuous EU initiative attempts to derail negotiations on TRIPS Waiver of COVID-19 monopolies

3 min
Banner deployed by MSF in front of the World Trade Organization (WTO) in Geneva calling on certain governments to stop blocking the landmark waiver proposal on intellectual property (IP) during the pandemic.
Statement
Statement |
26 April 2021
COVID-19
European Union

MSF feedback on EU statement at WTO COVID-19 vaccine equity event

1 min
Letter |
27 March 2020
COVID-19
European Union

Members of European Parliament ask the Commission: Make COVID-19 tools affordable and available

MSF Flag Photograph by Valérie Batselaere
Press release
Press release |
16 March 2020
COVID-19
European Union

COVID-19: Urgent help needed across European borders to protect medical staff

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury